title: Assessing Consistency in a Network Meta-Analysis to Compare Once Weekly Dulaglutide Versus Other Glp-1 Receptor Agonists in Patients with Type 2 Diabetes.
authors.affiliation: ICON Clinical Research UK Ltd., Oxford, UK.
authors.forename: N
authors.initials: N
authors.lastname: Hawkins
authors.affiliation: ICON Clinical Research UK Ltd., Oxford, UK.
authors.forename: A
authors.initials: A
authors.lastname: Padhiar
authors.affiliation: ICON Clinical Research UK Ltd., Oxford, UK.
authors.forename: J
authors.initials: J
authors.lastname: Thompson
authors.affiliation: ICON Clinical Research UK Ltd., Oxford, UK.
authors.forename: D A
authors.initials: DA
authors.lastname: Scott
authors.affiliation: ICON Clinical Research UK Ltd., Oxford, UK.
authors.forename: J N
authors.initials: JN
authors.lastname: Eaton
authors.affiliation: Eli Lilly and Company, Windlesham, UK.
authors.forename: N
authors.initials: N
authors.lastname: Varol
authors.affiliation: Eli Lilly and Company, Windlesham, UK.
authors.forename: K
authors.initials: K
authors.lastname: Norrbacka
authors.affiliation: Eli Lilly and Company, Indianapolis, IN, USA.
authors.forename: K S
authors.initials: KS
authors.lastname: Boye
authors.affiliation: Eli Lilly and Company, Bad Homburg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Nicolay